CRP/prealbumin,a novel inflammation-based score in predicting recurrence of gastric cancer:data of a

来源 :第十三届全国胃癌学术会议 | 被引量 : 0次 | 上传用户：zcf3031132044

【摘要】

：

Objective Numerous studies have demonstrated that inflammation-based score can effectively predict the overall survival of gastric cancer patients undergoing radical gastrectomy.

【作者】

：

Binbin Xu Changming Huang Chaohui Zheng Ping Li Jun Lu

【机构】

：

Department of Gastric Surgery,Fujian Medical University Union Hospital,Fuzhou 350001,Fujian Province

【出处】

：

第十三届全国胃癌学术会议

【发表日期】

：

2018年3期

【关键词】

：

gastric cancer inflammation-based score CRP/PAlb recurrence post-recurrence surv

下载到本地 , 更方便阅读

下载此文赞助VIP

声明 : 本文档内容版权归属内容提供方 , 如果您对本文有版权争议 , 可与客服联系进行内容授权或下架

论文部分内容阅读

　　Objective Numerous studies have demonstrated that inflammation-based score can effectively predict the overall survival of gastric cancer patients undergoing radical gastrectomy.

其他文献

Comparison of the Safety and Cost Between Uncut Roux-en-y Anastomosis and Billroth Ⅱ Anastomosis Aft

Objective Distal gastrectomy with D2 lymph node dissection was recommended as a standard surgery for distal gastric cancer patients.

会议

distal gastrectomygastric cancerUncut Roux-en-y anastomosisBillroth Ⅱ anastom

Use of Preoperative Body Mass Index to Predict the Prognosis of Diabetic Patients with non-metastasi

Objective The study was designed to investigate the effect of preoperative body mass index(BMI)on the survival outcome in T2DM patients with non-metastatic gastric cancer(GC)who underwent D2 gastrecto

会议

BMIType 2 diabetes mellitusGastric CancerX-tileOverall survival rate

Development and external validation of a simplified nomogram predicting individual survival after R0

Objective Previous research has developed three nomograms for the individual prediction of overall survival(OS)after gastric cancer(GC)surgery.

会议

NomogramOverall survivalPredictive abilityGastric cancerRadical surgery

S-1 combined oxaliplatin or cisplatin in neo-adjuvant chemotherapy for patients with stage Ⅱb/Ⅲ gast

Objective Patients with local advanced gastric cancer were recommended with neoadjuvant chemotherapy.

会议

oxaliplatinlocal advanced gastric canceroverall response ratesneoadjuvant che

SOX联合阿帕替尼方案用于进展期胃癌术前辅助治疗的肿瘤退缩疗效初步探索

目的初步探索SOX 联合阿帕替尼方案用于局部进展期胃癌术前辅助治疗的肿瘤退缩疗效，进而评估SOX 联合阿帕替尼方案在局部进展期胃癌术前治疗中的有效性。

会议

进展期胃癌新辅助治疗阿帕替尼肿瘤退缩分级

动静脉结合的SEEOX方案与全身给药的SOX方案对于局部晚期胃癌(Ⅲb,Ⅲc)术前化疗的对比研究(SVOSA)阶段总结

目的进展期胃癌的治疗是中国医生亟待解决的难题。术前化疗可以改善局部进展期胃癌的生存，但有效率不高。为提高术前化疗的效果，我们以采用动静脉结合的术前化疗方案，明显提高了有效率和生存率。

会议

进展期胃癌术前化疗动静脉联合化疗

肥胖对胃癌患者术后短期结果的影响:一项前瞻性队列研究

目的肥胖对胃癌切除术术后结果的影响仍未达成共识，内脏脂肪面积(visceral fat area VFA)是否是优于体重指数(body mass index BMI)的肥胖指标仍存在争议。

会议

胃癌肥胖体重指数内脏脂肪面积

Addition of peritonectomy to gastrectomy can predict good prognosis of gastric adenocarcinoma patien

Objective This study was to evaluate the prognosis of peritonectomy following gastrectomy for gastric adenocarcinoma patients with intraoperatively proven single P1/P2 carcinomatosis and to define the

会议

Gastric cancerchemotherapyperitoneal carcinomatosisperitonectomy

CRISPR-Cas9介导的PD-1基因敲除细胞毒性T淋巴细胞(CTL)细胞治疗在EBV阳性晚期恶性肿瘤的Ⅰ//Ⅱ期临床研究

目的观察EBV 阳性晚期恶性肿瘤在一线化疗失败后使用CRISPR-Cas9 介导的PD-1 基因敲除CTL(sgRNA-PD-1-CTL)细胞治疗的不良反应及疗效，探讨与疗效相关的免疫学指标，指导EBV 阳性恶性肿瘤的细胞免疫治疗。

会议

CRISPR-Cas9PD-1基因敲除CTL细胞治疗EBV阳性晚期恶性肿瘤

局部进展期胃癌术前化疗PCR预测模型的研究

目的在局部进展期胃癌(LAGC)的治疗中，术前化疗起着重要的作用。但是，术前化疗的反应在不同LAGC 患者中差异较大。目前大家认为，病理完全缓解(PCR)是LAGC 术前化疗效果好的一个不错的预测指标。但是预测PCR 的指标目前仍缺乏。

会议

局部进展期胃癌术前化疗病理完全缓解预测模型

CRP/prealbumin,a novel inflammation-based score in predicting recurrence of gastric cancer:data of a

其他学术论文